{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:12:33Z","timestamp":1774793553965,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FEMS Immunol Med Microbiol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1574-695x.2012.00992.x","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T10:05:50Z","timestamp":1337594750000},"page":"88-97","source":"Crossref","is-referenced-by-count":12,"title":["Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB\/C mice"],"prefix":"10.1093","volume":"66","author":[{"given":"Masood Alam","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Aljarbou","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy; Qassim University; Buraidah; Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Owais","sequence":"additional","affiliation":[{"name":"Interdisciplinary Biotechnology Unit; Aligarh Muslim University; Aligarh; India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0001|fim992-cit-0001","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/AAC.38.3.588","article-title":"Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice","volume":"38","author":"Agarwal","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0002|fim992-cit-0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10611860290007513","article-title":"Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters","volume":"10","author":"Agrawal","year":"2002","journal-title":"J Drug Target"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0003|fim992-cit-0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/mmy.38.5.343.353","article-title":"Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection","volume":"38","author":"Aguirre","year":"2000","journal-title":"Med Mycol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0004|fim992-cit-0004","volume-title":"Hematology: Principles and Procedures","author":"Brown","year":"1980"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0005|fim992-cit-0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1086\/322710","article-title":"Adjunctive immune therapy for fungal infections","volume":"33","author":"Casadevall","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0006|fim992-cit-0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566524054022567","article-title":"Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans","volume":"5","author":"Casadevall","year":"2005","journal-title":"Curr Mol Med"},{"issue":"Suppl 1","key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0007|fim992-cit-0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0008|fim992-cit-0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-2478(02)00066-4","article-title":"Peptide immunomodulators versus infection: an analysis","volume":"83","author":"Dutta","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0009|fim992-cit-0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1189\/jlb.1005603","article-title":"Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte","volume":"80","author":"Ghosn","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0010|fim992-cit-0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0076-6879(05)91016-1","article-title":"Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections","volume":"391","author":"Gupta","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0011|fim992-cit-0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-3083.2008.02101.x","article-title":"Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections","volume":"67","author":"Hamad","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0012|fim992-cit-0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/1061186031000119093","article-title":"Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B","volume":"11","author":"Khan","year":"2003","journal-title":"J Drug Target"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0013|fim992-cit-0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10611860600720384","article-title":"Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model","volume":"14","author":"Khan","year":"2006","journal-title":"J Drug Target"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0014|fim992-cit-0014","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2002.1278","article-title":"Systemic mycoses in the immunocompromised host: an update in antifungal therapy","volume":"53","author":"Kontoyiannis","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0015|fim992-cit-0015","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/421960","article-title":"Design of efficacy trials of cytokines in combination with antifungal drugs","volume":"39","author":"Kullberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0016|fim992-cit-0016","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2003.11.032","article-title":"Recombinant antibodies: a natural partner in combinatorial antifungal therapy","volume":"22","author":"Matthews","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0017|fim992-cit-0017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS - 100\u00a0years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0018|fim992-cit-0018","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dki454","article-title":"Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model","volume":"57","author":"Nasti","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0019|fim992-cit-0019","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A","author":"National Committee for Clinical Laboratory Standards","year":"1997"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0020|fim992-cit-0020","first-page":"67","article-title":"Development of liposomal polyene antibiotics: a historical perspective","volume":"6","author":"Nq","year":"2003","journal-title":"J Pharm Pharm Sci"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0021|fim992-cit-0021","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/AAC.48.12.4808-4812.2004","article-title":"Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B","volume":"48","author":"Offner","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0022|fim992-cit-0022","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2217\/fmb.10.93","article-title":"Mechanisms of Cryptococcal virulence and persistence","volume":"5","author":"Olszewski","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0023|fim992-cit-0023","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1046\/j.1432-1327.2000.01447.x","article-title":"Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development","volume":"267","author":"Owais","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0025|fim992-cit-0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1179\/joc.2001.13.4.347","article-title":"Host immune reactivity and antifungal chemotherapy: the power of being together","volume":"13","author":"Romani","year":"2001","journal-title":"J Chemother"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0026|fim992-cit-0026","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1128\/IAI.70.10.5684-5694.2002","article-title":"Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans","volume":"70","author":"Rude","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0027|fim992-cit-0027","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2165\/00003495-200464110-00002","article-title":"Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment","volume":"64","author":"Ruhnke","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0028|fim992-cit-0028","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2005.05397.x","article-title":"The immune response to fungal infections","volume":"129","author":"Shoham","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0029|fim992-cit-0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0196-9781(99)00019-4","article-title":"Tuftsin: on the 30-year anniversary of Victor Najjar's discovery","volume":"20","author":"Siemion","year":"1999","journal-title":"Peptides"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0024|fim992-cit-0024","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(84)81251-X","article-title":"Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers","volume":"178","author":"Singhal","year":"1984","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0030|fim992-cit-0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02558256","article-title":"A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions","volume":"42","author":"Singleton","year":"1965","journal-title":"J Am Oil Chem Soc"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0031|fim992-cit-0031","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1615\/CritRevImmunol.v27.i6.50","article-title":"Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity","volume":"27","author":"Vecchiarelli","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0032|fim992-cit-0032","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1034\/j.1600-6143.2002.20701.x","article-title":"Cryptococcosis in organ transplant recipients: an overview","volume":"2","author":"Vilchez","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0033|fim992-cit-0033","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"Voelz","year":"2010","journal-title":"Eukaryot Cell"},{"key":"10.1111\/j.1574-695X.2012.00992.x-BIB992-bib-0034|fim992-cit-0034","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/IR:35:3:191","article-title":"Immune response and immune therapy to Cryptococcus infections","volume":"35","author":"Zhou","year":"2006","journal-title":"Immunol Res"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/66\/1\/88\/19280739\/66-1-88.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T19:43:31Z","timestamp":1561751011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2012.00992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2012.00992.x","relation":{},"ISSN":["0928-8244"],"issn-type":[{"value":"0928-8244","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}